Tigermed Consulting And Qiming Venture Partners To Jointly Inject Funds Into MacroStat
This article was originally published in PharmAsia News
Executive Summary
China CRO Tigermed Consulting will join Qiming Venture Partners to inject funds into MacroStat, China's only international CRO, which specializes in statistical analysis for clinical trials. Tigermed will extend its business scope and strengthen its professional expertise in biostatistics through the collaboration, speeding up its clinical research globalization strategy. Established in 2005, Shanghai-based MacroStat China has formed strategic partnership with many pharmaceutical and biotech enterprises. After the new capital injection, MacroStat will be able to expand rapidly in the short term (Click here for more - Chinese Language)